Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATEGE-Fresenius Induction in Liver Transplantation
NCT00436722Phase 2Terminated
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jun 2006
- Primary completion
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in Liver transplant rejection, sponsored by Hospital Clínic de Barcelona. Started Jun 2006; status: terminated.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00436722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436722.